AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2014
Jan 24, 2014
34117_dirs_2014-01-24_aa926c5b-07ef-488e-a2f1-409cc26d9a14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-22
Reporting Person: BERMAN ROBERT ANDREW (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-22 | Common Stock | P | 23000 | $0.22 | Acquired | 64902 | Direct |
| 2014-01-22 | Common Stock | P | 22000 | $0.23 | Acquired | 86902 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6